GLIOMATCH 4th Consortium Meeting (online)
The 4th GLIOMATCH consortium meeting is held online on 17 November 2025 and focuses on scientific discussions and stakeholder involvement, including the distribution of the GLIOMATCH patient survey.
The 4th GLIOMATCH consortium meeting is held online on 17 November 2025 and focuses on scientific discussions and stakeholder involvement, including the distribution of the GLIOMATCH patient survey.
Make your plans to attend the 7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, held in conjunction with the 30th Society for Neuro-Oncology Annual Meeting & Education Day in beautiful Honolulu, Hawaii! This year’s meeting is particularly special, as we celebrate SNO’s 30th anniversary—a milestone that underscores three decades of progress, collaboration, and […]
Innovating Novel Combination Therapies & Maximising Preclinical & Clinical Development to Improve Glioblastoma Targeting & Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need The glioblastoma drug development space has been energized by Merck’s acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged […]
The 2nd annual meeting of the U-THI-Clust is held in Warsaw, Poland and hosted by HIT-GLIO at the Nencki Institute.
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting […]
The 5th Consortium Meeting is held in Barcelona, Spain and organised by SJD.
ESTRO 2025 focused on transformative innovation through partnership, via collaboration within our Radiation Oncology Community and especially with our scientific friends and partners from basic science, translational research and multidisciplinary cancer care. This journey will be continued, aiming to stay at the forefront of innovation. ESTRO 2026 will broach the opportunities to innovate our discipline […]